At1g11810 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g11810 antibody; F25C20.2F-box protein At1g11810 antibody
Target Names
At1g11810
Uniprot No.

Q&A

What is the At1g11810 gene in Arabidopsis thaliana and why is it significant for research?

At1g11810 encodes a protein in Arabidopsis thaliana that is part of the plant's regulatory pathways. The gene product (UniProt: Q9SA94) has been implicated in several developmental and stress response mechanisms in plants. When studying this protein, researchers typically employ antibody-based detection methods to track expression patterns under various conditions.

Detection methodologies for this protein include:

  • Western blotting (recommended dilution 1:500-1:2000)

  • Immunoprecipitation

  • Immunohistochemistry

  • ELISA-based quantification

For reliable results, researchers should validate antibody specificity using knockout or knockdown plant lines as negative controls to ensure signal specificity before proceeding with experimental applications .

What are the recommended sample preparation techniques for optimal At1g11810 detection?

Effective sample preparation is critical for successful antibody detection of At1g11810 protein. The following protocol has been optimized for Arabidopsis tissue:

  • Harvest fresh tissue and immediately flash-freeze in liquid nitrogen

  • Grind tissue to fine powder while maintaining frozen state

  • Extract proteins using a buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100

    • 0.5% sodium deoxycholate

    • Protease inhibitor cocktail

For subcellular localization studies, fractionation should be performed immediately after homogenization to preserve protein compartmentalization. When working with different tissue types, extraction protocols may require modification, particularly for tissues with high phenolic compound content or fibrous structure .

How should At1g11810 Antibody be optimally stored and handled to maintain activity?

To preserve antibody functionality and prevent degradation, adhere to these storage and handling guidelines:

  • Store antibody at -20°C for long-term storage (>1 month)

  • For working solutions, store at 4°C for up to 2 weeks

  • Avoid repeated freeze-thaw cycles (limit to <5 cycles)

  • Aliquot antibody upon receipt to minimize freeze-thaw cycles

  • Add carrier proteins (0.1% BSA) to diluted antibody solutions to prevent adsorption

  • Centrifuge antibody solution briefly before use to remove aggregates

Research indicates that antibody potency decreases approximately 10-15% with each freeze-thaw cycle, which can significantly impact experimental reproducibility, particularly in quantitative applications such as protein quantification in stress response studies .

What are the critical factors for optimizing At1g11810 Antibody concentration in immunoassays?

Antibody titration is essential for maximizing signal-to-noise ratio while minimizing reagent usage. Consider these methodological approaches:

  • Perform serial dilution testing across a range (1:100 to 1:5000)

  • Test multiple blocking agents (5% BSA, 5% non-fat milk, commercial blockers)

  • Evaluate background signal in negative controls at each concentration

  • Calculate signal-to-noise ratio for each condition

Research shows that using excessively high antibody concentrations often leads to unnecessarily high background without improving specific signal detection. For At1g11810 detection in Arabidopsis samples, concentrations can typically be reduced 5-10 fold from manufacturer recommendations without loss of biological information .

The relationship between antibody concentration, background, and specific signal follows this pattern:

Antibody DilutionBackground SignalSpecific SignalSignal-to-Noise Ratio
1:100HighHighLow
1:500MediumHighMedium
1:1000LowMedium-highHigh
1:5000Very lowLowMedium

Antibody performance is tissue-dependent, requiring separate optimization for different sample types .

How can I troubleshoot weak or inconsistent signals when using At1g11810 Antibody?

When encountering weak signals in At1g11810 detection, systematically evaluate these parameters:

  • Protein extraction efficiency:

    • Verify total protein yield using Bradford or BCA assay

    • Confirm protein integrity via Coomassie staining

  • Antibody binding conditions:

    • Optimize incubation time (increase from standard 1h to overnight at 4°C)

    • Adjust binding buffer composition (test different pH ranges, salt concentrations)

  • Detection system sensitivity:

    • Switch to more sensitive detection methods (ECL Plus instead of standard ECL)

    • Increase exposure time for western blots

    • For immunofluorescence, use signal amplification systems (tyramide signal amplification)

  • Target protein expression levels:

    • Confirm expression timing (developmental stage specificity)

    • Consider tissue-specific expression patterns

    • Test conditions known to upregulate the target gene

Research indicates that At1g11810 expression may be particularly sensitive to sample handling stress, potentially leading to artifactual expression changes if samples are not processed rapidly .

What controls are essential when using At1g11810 Antibody in plant research?

Rigorous controls are necessary to ensure experimental validity when working with plant antibodies:

  • Negative controls:

    • Knockout/knockdown lines for At1g11810

    • Secondary antibody-only controls

    • Pre-immune serum controls

  • Positive controls:

    • Recombinant At1g11810 protein

    • Samples with known high expression (specific tissues or conditions)

    • Spiked samples with known quantities of target protein

  • Loading/normalization controls:

    • Housekeeping proteins (actin, tubulin, GAPDH)

    • Total protein normalization (Ponceau staining)

  • Specificity controls:

    • Peptide competition assays

    • Cross-reactivity testing with related proteins

Researchers should document control results alongside experimental data to validate findings. For quantitative studies, technical replicates (minimum n=3) and biological replicates (minimum n=3) are recommended to establish statistical significance .

How can I use At1g11810 Antibody to study protein-protein interactions in planta?

For studying interaction partners of At1g11810, consider these methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Optimize lysis conditions to preserve protein complexes

    • Use gentle detergents (0.5% NP-40 or 0.1% Triton X-100)

    • Include protease inhibitors and phosphatase inhibitors

    • Perform IP at 4°C with overnight incubation

    • Elute with specific peptide rather than harsh conditions

  • Proximity labeling approaches:

    • Create fusion proteins with BioID or APEX2

    • Express in Arabidopsis via stable transformation

    • Induce proximity labeling and purify biotinylated proteins

    • Identify interaction partners via mass spectrometry

  • Fluorescence resonance energy transfer (FRET):

    • Generate fluorescent protein fusions with At1g11810

    • Co-express with candidate interaction partners

    • Measure FRET efficiency using confocal microscopy

When analyzing protein interactions, consider that plant proteins often form transient interactions dependent on developmental stage, tissue type, and environmental conditions. Design experiments to capture these dynamic relationships rather than assuming static interaction networks .

What are the considerations for using At1g11810 Antibody in cross-species studies?

When applying At1g11810 antibodies beyond Arabidopsis thaliana:

  • Sequence homology assessment:

    • Perform sequence alignment of immunogen region across target species

    • Calculate percent identity and similarity at epitope regions

    • Predict potential cross-reactivity based on conservation

  • Validation in target species:

    • Test antibody against recombinant protein from target species

    • Verify band size corresponds to predicted molecular weight

    • Perform peptide competition assays with species-specific peptides

  • Signal interpretation guidelines:

    • Account for potential post-translational modifications in different species

    • Consider different expression levels in homologous tissues

    • Validate with orthogonal methods (transcript analysis, mass spectrometry)

For closely related Brassicaceae species, cross-reactivity is likely, but validation is still necessary. For more distant species, epitope-specific custom antibodies may be required for reliable detection .

How can At1g11810 Antibody be adapted for high-throughput phenotypic screening?

For scaling At1g11810 protein analysis to high-throughput applications:

  • ELISA-based quantification:

    • Develop sandwich ELISA using capture and detection antibodies

    • Optimize antibody pair selection to minimize cross-reactivity

    • Establish standard curves using recombinant protein

    • Adapt to 384-well format for increased throughput

  • Automated western blotting:

    • Implement capillary-based protein detection systems

    • Optimize sample preparation for automation compatibility

    • Develop standardized analysis algorithms for quantification

  • High-content imaging:

    • Adapt immunofluorescence protocols to multi-well formats

    • Implement automated image acquisition and analysis

    • Develop computational pipelines for feature extraction

When designing high-throughput screens, prioritize robust quality control measures, including technical replicates, plate normalization methods, and positive/negative controls on each plate. Consider the use of oligo-conjugated antibodies for multiplexed detection, which allow simultaneous measurement of multiple proteins in single samples .

How should I interpret contradictory results between transcript and protein levels of At1g11810?

Discrepancies between mRNA and protein levels are common in plant systems and require careful interpretation:

  • Temporal considerations:

    • Protein synthesis and degradation lag behind transcriptional changes

    • Sample at multiple time points to capture expression dynamics

    • Analyze half-life differences between transcript and protein

  • Post-transcriptional regulation:

    • Assess miRNA targeting of At1g11810 transcript

    • Evaluate alternative splicing possibilities

    • Consider RNA-binding protein interactions

  • Post-translational modifications:

    • Investigate phosphorylation, ubiquitination, or other modifications

    • Test for proteolytic processing

    • Examine subcellular localization changes

  • Technical considerations:

    • Verify antibody detects all protein isoforms

    • Consider extraction method biases

    • Evaluate detection sensitivity differences

Research has demonstrated that in stress response studies, temporal delays between transcript induction and protein accumulation can range from 30 minutes to several hours, necessitating time-course experiments rather than single time-point analyses .

What statistical approaches are appropriate for quantifying At1g11810 expression across different experimental conditions?

For robust statistical analysis of At1g11810 protein levels:

  • Normalization strategies:

    • Normalize to loading controls (housekeeping proteins)

    • Apply total protein normalization (Ponceau staining)

    • Consider normalization to cell number for single-cell studies

  • Statistical testing:

    • For normally distributed data: ANOVA with post-hoc tests

    • For non-parametric data: Kruskal-Wallis with Mann-Whitney U follow-up

    • For time-course experiments: repeated measures ANOVA or mixed models

  • Multiple testing correction:

    • Apply Benjamini-Hochberg procedure for false discovery rate control

    • Use Bonferroni correction for stringent family-wise error rate control

    • Report both raw and adjusted p-values

  • Effect size reporting:

    • Calculate Cohen's d or Hedge's g for pairwise comparisons

    • Report confidence intervals alongside fold changes

    • Consider biological significance alongside statistical significance

For integrating At1g11810 expression data with other molecular data types, multivariate approaches such as principal component analysis or partial least squares discriminant analysis may reveal patterns not apparent in univariate analyses .

How can I integrate At1g11810 antibody-based data with other omics approaches for systems biology studies?

Multi-omics integration strategies for contextualizing At1g11810 protein data:

  • Correlation analysis:

    • Calculate Pearson or Spearman correlations between protein levels and:

      • Transcript abundance (RNA-seq)

      • Metabolite concentrations (metabolomics)

      • Epigenetic modifications (ChIP-seq)

    • Visualize using correlation heatmaps or networks

  • Network analysis:

    • Position At1g11810 within protein-protein interaction networks

    • Identify regulatory relationships using transcription factor binding data

    • Map metabolic pathway connections

  • Causal inference:

    • Apply Bayesian network modeling to infer directionality

    • Perform time-series analysis to establish temporal precedence

    • Validate with targeted perturbation experiments

  • Data visualization:

    • Create multi-omics data browsers for exploratory analysis

    • Implement dimension reduction techniques to visualize global patterns

    • Develop interactive visualization tools for hypothesis generation

When combining antibody-based detection with other technologies, consider technological biases and limitations. For instance, antibody detection may miss post-translational modifications that alter protein function without changing abundance, while transcript analysis cannot account for translational efficiency variations .

How can I optimize At1g11810 Antibody for use in single-cell protein analysis of plant tissues?

Single-cell protein detection requires specialized methodology:

  • Sample preparation:

    • Optimize protoplast isolation protocols for specific tissues

    • Minimize stress responses during preparation

    • Preserve cell viability throughout processing

  • Detection strategies:

    • Adapt flow cytometry protocols using fluorophore-conjugated secondary antibodies

    • Implement imaging mass cytometry for spatial resolution

    • Consider oligo-conjugated antibodies for single-cell multi-protein profiling

  • Validation approaches:

    • Perform immunofluorescence on intact tissues for comparison

    • Correlate with single-cell RNA-seq data

    • Use reporter lines for orthogonal validation

What are the considerations for using At1g11810 Antibody in studying protein dynamics during environmental stress responses?

For capturing dynamic protein changes during stress responses:

  • Temporal resolution optimization:

    • Implement rapid sampling strategies (seconds to minutes)

    • Consider automated sampling systems for consistency

    • Create time-course designs with appropriate intervals

  • Subcellular localization monitoring:

    • Track protein translocation between compartments

    • Assess changes in membrane association

    • Monitor formation of stress-induced protein bodies

  • Protein modification analysis:

    • Detect phosphorylation changes using phospho-specific antibodies

    • Monitor ubiquitination status with co-immunoprecipitation

    • Assess oligomerization state changes

  • Stress application considerations:

    • Standardize stress application methods for reproducibility

    • Control for secondary stress responses

    • Consider dose-response relationships

Research on stress-responsive proteins suggests that rapid changes in protein localization often precede changes in total protein abundance, necessitating subcellular fractionation approaches alongside total protein analysis .

How can computational modeling enhance interpretation of At1g11810 Antibody-derived data?

Computational approaches to maximize insights from antibody-based data:

  • Quantitative modeling:

    • Develop ordinary differential equations to model protein dynamics

    • Implement stochastic models for low-abundance proteins

    • Create agent-based models for spatial protein dynamics

  • Machine learning applications:

    • Apply supervised learning for pattern recognition in protein expression data

    • Use unsupervised learning to identify novel protein state clusters

    • Implement deep learning for image analysis of immunofluorescence data

  • Integrative modeling:

    • Construct gene regulatory networks incorporating protein data

    • Develop multi-scale models linking molecular to phenotypic levels

    • Create predictive models of protein responses to environmental changes

  • Simulation approaches:

    • Perform in silico experiments to test hypotheses

    • Simulate perturbations to predict system responses

    • Identify key control points through sensitivity analysis

When applying computational approaches, ensure models are biologically grounded and experimentally testable. The most valuable models generate specific, testable predictions that can guide further experimental work rather than simply recapitulating existing data .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.